相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Allergen immunotherapy with the hypoallergenic B-cell epitope-based vaccine BM32 modifies IL-10-and IL-5-secreting T cells
Michele Myriam Rauber et al.
ALLERGY (2020)
Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity
Angelika Tscheppe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Virus-like particles displaying major HDM allergen Der p 2 for prophylactic allergen immunotherapy
Tewarit Soongrung et al.
ALLERGY (2020)
All the small things: How virus-like particles and liposomes modulate allergic immune responses
Bernhard Kratzer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
The Cost-Effectiveness of Allergen Immunotherapy Compared with Pharmacotherapy for Treatment of Allergic Rhinitis and Asthma
Linda S. Cox et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2020)
Novel Therapies for Treatment of Food Allergy
Sultan Albuhairi et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2020)
Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens
Federico Storni et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Allergen immunotherapy and asthma
Maria Angela Tosca et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)
Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model
Bernhard Kratzer et al.
ALLERGY (2019)
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy The PEPITES Randomized Clinical Trial
David M. Fleischer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Molecular diagnosis for allergen immunotherapy
Paolo Maria Matricardi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Maternal allergen-specific IgG might protect the child against allergic sensitization
Christian Lupinek et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Double-blind, randomized, placebo-controlled trial of allergen-specific immunotherapy with the major allergen Alt a 1
Ana Isabel Tabar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients
Carla Winkler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial
Hanisah Sharif et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Recombinant allergens for immunotherapy: state of the art
Yury Zhernov et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety
Derek K. Chu et al.
LANCET (2019)
A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens
Huey-Jy Huang et al.
ALLERGY (2019)
Duration of allergen immunotherapy for inhalant allergy
Martin Penagos et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Decision-making for pediatric allergy immunotherapy for aeroallergens: a narrative review
Miguel Tortajada-Girbes et al.
EUROPEAN JOURNAL OF PEDIATRICS (2019)
Tracing IgE-Producing Cells in Allergic Patients
Julia Eckl-Dorna et al.
CELLS (2019)
Worldwide perspectives on venom allergy
Peter Korosec et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2019)
Intralymphatic Immunotherapy: Update and Unmet Needs
Gabriela Senti et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Role of Der p 1-specific B cells in immune tolerance during 2 years of house dust mite-specific immunotherapy
Tadech Boonpiyathad et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms
Raffaela Campana et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Epicutaneous immunotherapy for peanut allergy modifies IgG4 responses to major peanut allergens
Stef J. Koppelman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Engineering of structural variants of the major peanut allergens Ara h 2 and Ara h 6 for allergen-specific immunotherapy
Merima Bublin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy
Kuan-Wei Chen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Detection of genuine grass pollen sensitization in children by skin testing with a recombinant grass pollen hybrid
Nikolaos Douladiris et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2019)
Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses
Julia Eckl-Dorna et al.
FRONTIERS IN IMMUNOLOGY (2019)
Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG4 response
Julia Eckl-Dorna et al.
EBIOMEDICINE (2019)
Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity
N. Najafi et al.
SCIENTIFIC REPORTS (2019)
Allergen immunotherapy in atopic dermatitis
Erminia Ridolo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients
R. Moesges et al.
ALLERGY (2018)
Short course of grass allergen peptides immunotherapy over 3weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial
R. Moesges et al.
ALLERGY (2018)
The challenges of preventing food allergy
Helen R. Fisher et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Next-Generation of Allergen-Specific Immunotherapies: Molecular Approaches
Mirela Curin et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2018)
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32
Verena Niederberger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Functional and Immunoreactive Levels of IgG4 Correlate with Clinical Responses during the Maintenance Phase of House Dust Mite Immunotherapy
Mulin Feng et al.
JOURNAL OF IMMUNOLOGY (2018)
Molecular sensitization patterns and influence of molecular diagnosis in immunotherapy prescription in children sensitized to both grass and olive pollen
Ana Martinez-Canavate Burgos et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2018)
Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement
J. M. Orengo et al.
NATURE COMMUNICATIONS (2018)
The economic advantage of allergen immunotherapy over drug treatment in respiratory allergy
Cristoforo Incorvaia et al.
JOURNAL OF MEDICAL ECONOMICS (2018)
Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice
Alina Neunkirchner et al.
EBIOMEDICINE (2018)
DNA and mRNA vaccination against allergies
Sandra Scheiblhofer et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2018)
Allergen Extracts for In Vivo Diagnosis and Treatment of Allergy: Is There a Future?
Rudolf Valenta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Placebo effects in allergen immunotherapy: an experts' opinion
Anthony J. Frew et al.
ALLERGO JOURNAL (2018)
Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life
X. Huang et al.
ALLERGY (2018)
Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells
P. Engeroff et al.
ALLERGY (2018)
House dust mites as potential carriers for IgE sensitization to bacterial antigens
S. Dzoro et al.
ALLERGY (2018)
Recombinant allergy vaccines based on allergen-derived B cell epitopes
Rudolf Valenta et al.
IMMUNOLOGY LETTERS (2017)
Greater Real-Life Diagnostic Efficacy of Allergen Molecule-Based Diagnosis for Prescription of Immunotherapy in an Area with Multiple Pollen Exposure
Ulbosin Saltabayeva et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2017)
Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA study
Valerie Siroux et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope-based grass pollen allergy vaccine with allergen extract-based vaccines
Milena Weber et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life
Daniela Posa et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults
Stacie M. Jones et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers
Mohamed H. Shamji et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Strategies for long-term preservation of kidney graft function
Thomas Wekerle et al.
LANCET (2017)
Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance
Raffaela Campana et al.
SEMINARS IN IMMUNOLOGY (2017)
Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study
Yan Su et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Transplantation Tolerance through Hematopoietic Chimerism: Progress and Challenges for Clinical Translation
Benedikt Mahr et al.
FRONTIERS IN IMMUNOLOGY (2017)
Detection of IgE Reactivity to a Handful of Allergen Molecules in Early Childhood Predicts Respiratory Allergy in Adolescence
Magnus Wickman et al.
EBIOMEDICINE (2017)
Epicutaneous allergen application preferentially boosts specific T cell responses in sensitized patients
Raffaela Campana et al.
SCIENTIFIC REPORTS (2017)
T follicular helper (Tfh) cells in normal immune responses and in allergic disorders
G. Varricchi et al.
ALLERGY (2016)
Specific Antibodies for the detection of Alternaria Allergens and the Identification of Cross-Reactive Antigens in Other Fungi
Teresa E. Twaroch et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2016)
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
Rudolf Valenta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study
Francois Spertini et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
EAACI Molecular Allergology User's Guide
P. M. Matricardi et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2016)
Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies
Martin Rosewich et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2016)
Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy
Ulrike Baranyi et al.
EBIOMEDICINE (2016)
Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection
Carolin Cornelius et al.
EBIOMEDICINE (2016)
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
Petra Zieglmayer et al.
EBIOMEDICINE (2016)
Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials
G. Senti et al.
ALLERGY (2015)
Genetics of allergy and allergic sensitization: common variants, rare mutations
Klaus Bonnelykke et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Regulatory B Cells: Origin, Phenotype, and Function
Elizabeth C. Rosser et al.
IMMUNITY (2015)
Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy
Laurian Zuidmeer-Jongejan et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2015)
In vivo allergenic activity of a hypoallergenic mutant of the major fish allergen Cyp c 1 evaluated by means of skin testing
Nikolaos Douladiris et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Antibody conjugates bispecific for intercellular adhesion molecule 1 and allergen prevent migration of allergens through respiratory epithelial cell layers
Christoph Madritsch et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients
Verena Niederberger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
Margarete Focke-Tejkl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
George Du Toit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Olive, grass or both? Molecular diagnosis for the allergen immunotherapy selection in polysensitized pollinic patients
C. Moreno et al.
ALLERGY (2014)
Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides
Francois Spertini et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Conversion of Der p 23, a New Major House Dust Mite Allergen, into a Hypoallergenic Vaccine
Srinita Banerjee et al.
JOURNAL OF IMMUNOLOGY (2014)
Advances in allergen-microarray technology for diagnosis and monitoring of allergy: The MeDALL allergen-chip
Christian Lupinek et al.
METHODS (2014)
Preventive sublingual immunotherapy in preschool children: First evidence for safety and pro-tolerogenic effects
Zsolt Szepfalusi et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2014)
Molecular diagnosis and immunotherapy
Joaquin Sastre
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Natural killer cells in patients with allergic diseases
Gunnur Deniz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy
Menno A. Kiel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Prophylactic use of sublingual allergen immunotherapy in high-risk children: A pilot study
Patrick G. Holt et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses
Willem van de Veen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
A Nonallergenic Birch Pollen Allergy Vaccine Consisting of Hepatitis PreS-Fused Bet v 1 Peptides Focuses Blocking IgG toward IgE Epitopes and Shifts Immune Responses to a Tolerogenic and Th1 Phenotype
Katharina Marth et al.
JOURNAL OF IMMUNOLOGY (2013)
A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnostics
Giorgio Walter Canonica et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2013)
Persistent molecular microchimerism induces long-term tolerance towards a clinically relevant respiratory allergen
U. Baranyi et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Varying Allergen Composition and Content Affects the in vivo Allergenic Activity of Commercial Dermatophagoides pteronyssinus Extracts
Anne Casset et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study
Gabriela Senti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
Gabriela Senti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives
Birgit Linhart et al.
VACCINE (2012)
Skin Prick Test Extracts for Dog Allergy Diagnosis Show Considerable Variations Regarding the Content of Major and Minor Dog Allergens
Mirela Curin et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2011)
A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS
Katarzyna Niespodziana et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies
Louisa K. James et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Altered IgE epitope presentation: A model for hypoallergenic activity revealed for Bet v 1 trimer
Raffaela Campana et al.
MOLECULAR IMMUNOLOGY (2011)
Characterization and comparison of commercially available mite extracts for in vivo diagnosis
B. Brunetto et al.
ALLERGY (2010)
From Allergen Genes to Allergy Vaccines
Rudolf Valenta et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Fluorosomes: a convenient new reagent to detect and block multivalent and complex receptor-ligand interactions
Hans J. Kueng et al.
FASEB JOURNAL (2010)
Molecular composition and biological activity of commercial birch pollen allergen extracts
M. Focke et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy
Gabriela Senti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy
Nicole Schmitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Heterogeneity of commercial timothy grass pollen extracts
M. Focke et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis
Gabrielle Pauli et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells
Ulrike Baranyi et al.
JOURNAL OF IMMUNOLOGY (2008)
Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
Gabriela Senti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma:: 10-year follow-up on the PAT study
L. Jacobsen et al.
ALLERGY (2007)
A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy
Ines Swoboda et al.
JOURNAL OF IMMUNOLOGY (2007)
Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data
Stephan C. Bischoff
NATURE REVIEWS IMMUNOLOGY (2007)
Immunological mechanisms of allergen-specific immunotherapy
Mark Larche et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Direct stimulation of T lymphocytes by immunosomes: Virus-like particles decorated with T cell receptor/CD3 ligands plus costimulatory molecules
Sophia V. Derdak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Five-year follow-up on the PAT study:: specific immunotherapy and long-term prevention of asthma in children
B. Niggemann et al.
ALLERGY (2006)
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Thomas M. Kuendig et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis
SR Durham et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Allergen-specific immunotherapy with recombinant grass pollen allergens
M Jutel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Monophosphoryl lipid A (MPL®) promotes allergen-induced immune deviation in favour of Th1 responses
F Puggioni et al.
ALLERGY (2005)
Vaccination with genetically engineered allergens prevents progression of allergic disease
V Niederberger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells
EA Moseman et al.
JOURNAL OF IMMUNOLOGY (2004)
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies
N Mothes et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System™
R Movérare et al.
ALLERGY (2002)
Recombinant marker allergens: Diagnostic gatekeepers for the treatment of allergy
L Kazemi-Shirazi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study)
C Möller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment
R Hiller et al.
FASEB JOURNAL (2002)
Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes TH1 cytokine expression while downregulating TH2 cytokine expression in PBMCs from human patients with ragweed allergy
JD Marshall et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1
S Vrtala et al.
FASEB JOURNAL (2001)
A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections
KJ Drachenberg et al.
ALLERGY (2001)
分享论文
